The government has agreed to end the requirements for centralized guidance for these groups following expert clinical advice, so those previously thought to be clinically highly vulnerable should be shielded again. Will not be advised. The termination of the Shield Program will follow the suspension of Shield Guidance after April 1, 2021.
This decision is based on much more information available about the virus, which makes individuals more or less vulnerable, the success of the COVID-19 vaccination program, and the emergence of proven therapies such as dexamethasone and tocilizumab. .. Clinical care pathway.
The shield was introduced at the beginning of the COVID-19 pandemic as one of the few interventions available to help those who are considered to be at greatest risk of serious viral illness.
This was the right decision at the time to protect the most vulnerable during the first wave of viruses and little known about their risk characteristics, but Shield’s advice was very limited and one. For the people of the club, the mental and physical well-being that had a significant impact on people’s lives and their lives.
Since July 19th, the guidance for people who are clinically very vulnerable has been to follow the same advice as others, along with suggestions for additional precautions that people may want to take. Studies and assessments of several individual clinical groups will continue.
This will move the country to a pre-COVID-19 situation. In this situation, people managed their condition with a medical professional who best knew the needs of the individual patient.
For people who may have a weakened immune response, such as those with immunodeficiency or certain cancers such as blood (blood) malignancies, and more generally at risk of infection. Recommended, I came back to the daily personalized advice from the relevant experts.
People previously on the shielded patient list will receive a letter from the government within a few days to inform them of this decision.
The government will continue to assess the circumstances and risks posed by COVID-19 and, based on clinical advice, will respond accordingly to keep the most vulnerable people safe. Individuals should consider advice from their medical professionals as to whether additional precautions are appropriate for them.
People over the age of 16 who are in underlying health at high risk of severe COVID-19 also prioritize booster immunization and contact with immunosuppressed individual adult households. This ensures that the protection provided by the vaccine is maintained during the winter.
Vaccinations as part of the booster program will begin next week and the NHS will contact people directly to let them know it’s their turn.
Jenny Harries, Chief Executive Officer of the UK Health and Security Agency, said:
Since the inception of the pandemic, the NHS has administered millions of life-saving COVID-19 vaccines and treatments. As a result, people who were originally considered to be clinically very vulnerable are advised to follow the same from step 4 (July 19th). Guidance like everyone else.
Due to this progress, the government does not anticipate the need to reissue Shield’s advice to this large group, but will continue to assess the risks from COVID-19 to the most vulnerable.
Patients who are more commonly at risk of infection, for example patients with blood cancer and who may remain inadequately protected after other vaccinations, are part of routine care. We encourage you to discuss this with an expert.
I urge everyone else to follow the guidance and continue to take precautions to make you feel safe.
If most vulnerable, the shield program will terminate
SourceIf most vulnerable, the shield program will terminate